Cobenfy Falls Short as Add-On Therapy for Schizophrenia ...Middle East

Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a statistically significant difference, top-line data show. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Cobenfy Falls Short as Add-On Therapy for Schizophrenia )

Also on site :

• Women Who Become Lonelier as They Get Older Usually Display These 6 Subtle Behaviors, Psychologists Say
• Fewer parties, less glam as DC readies for 'weird' Trump 2.0 Correspondents' dinner
• Neusoft Launches Three Product Portfolios for AI-Powered Intelligent Mobility at Auto Shanghai 2025